What Medical Marijuana Teaches Us About Disruption

The Drug Enforcement Agency labels marijuana a Schedule I drug, a classification for “drugs, substances or chemicals with no currently accepted medical use and a high potential for abuse.”

Most in the United States disagree. The Pew Research Center reports that just over three-quarters of Americans believe marijuana has legitimate medical uses, and significant majorities within states think it should be legalized.

This puts pharma businesses in an awkward position, as new product development or even external communication could rankle the DEA.

Fortunately, controversial topics generate buzz and data, which brands can use to better understand the marketplace. The Cision Global Insights team analyzed more than 360,000 medical marijuana discussions around the world.

By researching blogs, forums, social channels and digital publications from 14 countries, they discovered where medical marijuana conversations took place, the most popular topics discussed and people’s most widely-held beliefs.

...
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.